LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

CSF Cytokine Characteristics Defined from Children with Meningitis

By LabMedica International staff writers
Posted on 21 Jan 2020
Print article
Image: The BD Bactec FX40: the blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections (Photo courtesy of Becton, Dickinson and Company).
Image: The BD Bactec FX40: the blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections (Photo courtesy of Becton, Dickinson and Company).
Enteroviral meningitis (EVM) are the most common etiological agent for viral encephalitis, and are predominantly reported among children and always present as a milder clinical illness than other infectious causes which only need supportive therapy.

However, bacterial meningitis (BM) is still associated with a high morbidity and mortality rate. Appropriate antibiotics treatment is essential to optimize outcomes. Cytokines are regarded as having important roles in meningeal inflammation in patients with central nervous system (CNS) infection.

Clinical scientists at the Zhejiang University School of Medicine (Hangzhou, China) carried a retrospective study and collected cerebrospinal fluid CSF and/or blood specimens for microbiological culture, viruses, and cytokine detection. Patients were categorized into three groups: EVM group: Patients with EVM were confirmed by the presence of pleocytosis and detection of enteroviral nucleic acid detection in CSF using polymerase chain reaction (PCR); BM group: Patients with bacterial meningitis who were diagnosed as having significant CSF white blood cell counts; Control group: children with febrile seizures who underwent lumbar puncture and had normal CSF.

CSF specimens and blood samples were taken for microbiological culture. Samples were injected into children's blood culture bottles (BACTEC FX400, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) for enrichment culture. MALDI‐TOF (BRUKER, Billerica, MA, USA) was used for bacterial identification and VITEK 2 compact (bioMérieux, Marcy-l'Étoile, France) for bacterial drug sensitivity. Serum and CSF concentration of cytokines interleukin (IL)‐2, IL‐6, IL‐10, tumor necrosis factor (TNF), and interferon (IFN)‐γ were quantitatively determined by the CBA kit–BD CBA Human Th1/Th2 Cytokine Kit II (BD Biosciences, San Jose, CA, USA). The detection of EVs was performed by using commercial one‐step real‐time RT‐PCR assay kit.

The scientists reported that 43 patients were confirmed with meningitis, 27 patients with EVM, and 16 with BM. Children with EVM were older compared with BM and control group. Serum IL‐6 and serum IL‐10 were lower in EVM group than BM and control group. IL‐6, IL‐10, and IFN‐γ levels showed obviously increase in CSF in EVM group, while only IL‐6 increased in CSF in BM group. CSF concentrations of cytokines IL‐6, IL‐10, TNF, and IFN‐γ in children with EVM and BM were both higher than control group, but compared EVM group to BM group, CSF IL‐2, TNF, and IFN‐γ showed no difference between two groups.

The authors concluded that CSF cytokines elevated in both virus and bacterial meningitis, while serum elevation only occurred in bacterial infection. However, they could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ. The study was published on January 8, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Zhejiang University School of Medicine
Becton, Dickinson and Company
BRUKER
bioMérieux
BD Biosciences


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.